MedTrace Logo

CONtrolled Focal Fibrous Band Release Method Study

NCT04743635 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2023-06-06

Study results available
· View outcomes & findings →

Summary

Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.

Conditions

  • Cellulite

Interventions

DEVICE

Avéli device

Minimally invasive single procedure with the Avéli device for reduction in the appearance of cellulite in the thighs and buttocks.

Sponsors & Collaborators

  • Revelle Aesthetics, Inc

    lead INDUSTRY

Principal Investigators

  • Dr. G. William Stevens, MD · Marina Plastic Surgery

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-07
Primary Completion
2021-06-14
Completion
2022-03-04
FDA Device
Yes

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04743635 on ClinicalTrials.gov